Published in Women's Health Weekly, June 9th, 2005
University of Pennsylvania researchers in psychiatry conducted their study "to evaluate attitudes about the benefits, limitations, and risks of genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations and explore testing intentions in African American women at increased risk for hereditary breast cancer."
"Attitudes and intentions were evaluated by telephone in African American women (n=74) at moderate and high risk for having a BRCA1/2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.